Latest features in GaBI Journal, 2013, Issue 3
Italy’s final position paper on biosimilars and new price and reimbursement pathway
Biosimilar monoclonal antibodies—challenges and opportunities in Europe
Regional tenders on biosimilars in Italy: potentially competitive?
Assessing biosimilarity using the method of generalized pivotal quantities
Steps to ensure adequate supply of biological medicines: considerations for the healthcare provider
Safety and toxicity of biosimilars—EU versus US regulation
Licensing and prescribing biosimilars in Australia
US state legislation on biosimilars substitution
Biosimilar monoclonal antibodies – time for a regulatory rethink
Source URL: https://gabi-journal.net/20133-gabi-journal-table-of-contents.html
Copyright ©2024 GaBI Journal unless otherwise noted.